J&J to ship children’s medicine amid House committee hearing
WASHINGTON Johnson & Johnson said Wednesday that it plans to ship limited quantities of one of its children’s medicines following a nationwide recall.
J&J CEO William Weldon said nearly 1 million bottles of the medicine — which he did not disclose — will be available for release next week. The drug maker met with the House Committee on Oversight and Government Reform on Thursday to examine the circumstances surrounding J&J’s recall of more than 135 million bottles of infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare, including children’s Tylenol, infant’s Tylenol, children’s Motrin and children’s Benadryl.
On Sept. 16, J&J’s consumer group chair Colleen Goggins said she would retire from her post on March 1, 2011.
HerbaSway introduces Last Round to cap off night
WALLINGFORD, Conn. HerbaSway has introduced a hangover support in a ready-to-drink single “shot.”
Last Round is a 2.5-oz. bottle that contains such ingredients as kudzu root, stevia and green tea extracts. Last Round works by removing the effects of alcohol, “relaxing” the flow of blood and oxygen to the brain, and detoxifying the body so users avoid headaches, dry mouth and other ailments associated with hangovers, the company said. HerbaSway also recommended drinking one 2.5-oz. bottle of Last Round just before bedtime.
“Our whole philosophy at HerbaSway revolves around living a natural lifestyle, and as a natural hangover support, Last Round fits perfectly alongside our other product lines,” said Robert Wolfson, president of HerbaSway. “Drinking moderately and responsibly also fits into our philosophy, but we recognize that there are times when people go a little overboard. On these occasions, a final shot of Last Round provides protection against hangovers the next day. As we say on the bottle, it’s the best way to end a night of drinking.”
Last Round is available online and at retail shops nationwide, including Whole Foods. It is sold in two-packs, six-packs, 12-packs and party packs of 50 bottles.
Subsequent offering period expires for Sun Pharma
MUMBAI, India Sun Pharmaceutical Industries’ subsequent offering period by one of its subsidiaries for all outstanding ordinary shares for drug maker Taro has expired, Sun Pharma said Wednesday.
Sun subsidiary Alkaloida Chemical Company Exclusive Group was informed that 29,382 ordinary shares of Taro had been tendered as of Tuesday. During the pendency of the subsequent offering period, no additional shares have been tendered. All tendered ordinary shares were accepted for payment.